Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$901,923
+$15,057 QoQ
Shares Held
5,755
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#656
of 1,603 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calydon Capital holds $35,751,780 across 10 Drug Manufacturers - General names. NVS ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,979 | $9,391,556 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,233 | $7,357,157 | |
| 3 | AMGN |
Amgen Inc
|
20,308 | $7,353,932 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
123,497 | $7,115,897 | |
| 5 | LLY |
ELI LILLY & Co
|
1,509 | $1,809,940 | |
| 6 | AZN |
Astrazeneca PLC
|
4,923 | $933,499 | |
| 7 | NVS |
Novartis AG
This page
|
5,755 | $901,923 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,772 | $356,202 |
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $901,923 | 5,755 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $886,866 | 5,806 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $789,581 | 5,727 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $810,476 | 6,320 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,479,710 | 12,228 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $677,798 | 6,080 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $591,742 | 6,081 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $699,321 | 6,080 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $647,276 | 6,080 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $588,118 | 6,080 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $200,829 | 1,989 | Shares | Sole | 2024-02-07 | |
| 2022-12-31 | $368,776 | 4,065 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $335,888 | 4,419 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $280,047 | 3,313 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||